We regret to report that long term Biogen Inc. (NASDAQ:BIIB) shareholders have had that experience, with the share price dropping 20% in three years, versus a market return of about 89%.

Investors in Biogen Inc (Symbol: BIIB) saw new options become available today, for the September 2025 expiration. One of the key data points that goes into the price an option buyer is willing to ...

Investors in Biogen Inc (Symbol: BIIB) saw new options begin trading today, for the May 10th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the BIIB options ...

At $310.58, the average BIIB stock price target of $310.58 suggests a modest upside potential of 1.8% from current levels. Biogen stock has rallied over 27% so far this year. IQVIA Holdings (IQV ...

Biogen (NASDAQ:BIIB) has had a great run on the share market with its stock up by a significant 30% over the last three months. Given the company's impressive performance, we decided to study its ...

Biogen (BIIB) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

In the latest market close, Biogen Inc. (BIIB) reached $247.52, with a +1.1% movement compared to the previous day. This change outpaced the S&P 500's 0.76% gain on the day. Elsewhere, the Dow ...

Biogen Inc. (BIIB) closed the most recent trading day at $285.37, moving -1.29% from the previous trading session. This move lagged the S&P 500's daily loss of 0.74%. Elsewhere, the Dow lost 0.9% ...

That downside risk was realized by Biogen Inc. (NASDAQ:BIIB) shareholders over the last year, as the share price declined 15%. That's well below the market return of 60%.

Biogen Inc. (BIIB) closed at $338.24 in the latest trading session, marking a -0.2% move from the prior day. This change lagged the S&P 500's daily gain of 0.03%. Prior to today's trading, shares ...